Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

23 Aug 2019 Evaluate

Glenmark Pharmaceuticals has informed about media release titled: ‘Glenmark Pharmaceuticals receives ANDA approval for Fulvestrant Injection, 250 mg/5 mL (50 mg/mL)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..